The role of genetics in Parkinson’s disease: a large cohort study in Chinese mainland population
- 1 July 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Brain
- Vol. 143 (7), 2220-2234
- https://doi.org/10.1093/brain/awaa167
Abstract
This study aimed to determine the mutational spectrum of familial Parkinson’s disease and sporadic early-onset Parkinson’s disease (sEOPD) in a mainland Chinese population and the clinical features of mutation carriers. We performed multiplex ligation-dependent probe amplification assays and whole-exome sequencing for 1676 unrelated patients with Parkinson’s disease in a mainland Chinese population, including 192 probands from families with autosomal-recessive Parkinson’s disease, 242 probands from families with autosomal-dominant Parkinson’s disease, and 1242 sEOPD patients (age at onset ≤ 50). According to standards and guidelines from the American College of Medical Genetics and Genomics, pathogenic/likely pathogenic variants in 23 known Parkinson’s disease-associated genes occurred more frequently in the autosomal-recessive Parkinson’s disease cohort (65 of 192, 33.85%) than in the autosomal-dominant Parkinson’s disease cohort (10 of 242, 4.13%) and the sEOPD cohort (57 of 1242, 4.59%), which leads to an overall molecular diagnostic yield of 7.88% (132 of 1676). We found that PRKN was the most frequently mutated gene (n = 83, 4.95%) and present the first evidence of an SNCA duplication and LRRK2 p.N1437D variant in mainland China. In addition, several novel pathogenic/likely pathogenic variants including LRRK2 (p.V1447M and p.Y1645S), ATP13A2 (p.R735X and p.A819D), FBXO7 (p.G67E), LRP10 (c.322dupC/p.G109Rfs*51) and TMEM230 (c.429delT/p.P144Qfs*2) were identified in our cohort. Furthermore, the age at onset of the 132 probands with genetic diagnoses (median, 31.5 years) was about 14.5 years earlier than that of patients without molecular diagnoses (i.e. non-carriers, median 46.0 years). Specifically, the age at onset of Parkinson’s disease patients with pathogenic/likely pathogenic variants in ATP13A2, PLA2G6, PRKN, or PINK1 was significantly lower than that of non-carriers, while the age at onset of carriers with other gene pathogenic/likely pathogenic variants was similar to that of non-carriers. The clinical spectrum of Parkinson’s disease-associated gene carriers in this mainland Chinese population was similar to that of other populations. We also detected 61 probands with GBA possibly pathogenic variants (3.64%) and 59 probands with GBA p.L444P (3.52%). These results shed insight into the genetic spectrum and clinical manifestations of Parkinson’s disease in mainland China and expand the existing repertoire of pathogenic or likely pathogenic variants involved in known Parkinson’s disease-associated genes. Our data highlight the importance of genetic testing in Parkinson’s disease patients with age at onset < 40 years, especially in those from families with a recessive inheritance pattern, who may benefit from early diagnosis and treatment.Keywords
Funding Information
- national key plan for scientific research and development of China (2016YFC1306000, 2017YFC0909101, 2017YFC0840100, 2017YFC0840104)
- National Natural Science Foundation of China (81430023)
- Central Public-Interest Scientific Institution Basal Research Fund of Chinese Academy of Medical Sciences (2018-12M-HL-025)
- Young Elite Scientist Sponsorship Program by CAST (2018QNRC001)
- Innovation-Driven Project of Central South University (20180033040004)
- Hunan Science Funds for Distinguished Young Scholar (2017JJ1037)
- Department of Science & Technology of Hunan Province (2019RS1010)
- Central South University (2020CX016)
This publication has 72 references indexed in Scilit:
- PLA2G6 gene mutation in autosomal recessive early-onset parkinsonism in a Chinese cohortNeurology, 2011
- Frequency of Known Mutations in Early-Onset Parkinson DiseaseArchives of Neurology, 2010
- Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's diseaseMovement Disorders, 2010
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing dataGenome Research, 2010
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing dataNucleic Acids Research, 2010
- Glucocerebrosidase Gene L444P mutation is a risk factor for Parkinson's disease in Chinese populationMovement Disorders, 2010
- Predictors of Parkin Mutations in Early-Onset Parkinson DiseaseArchives of Neurology, 2010
- A novel LRRK2 mutation in a mainland Chinese patient with familial Parkinson's diseaseNeuroscience Letters, 2010
- Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's DiseaseThe New England Journal of Medicine, 2009
- Mutation analysis of Parkin, PINK1, DJ‐1 and ATP13A2 genes in Chinese patients with autosomal recessive early‐onset ParkinsonismMovement Disorders, 2008